This Injectable Hydrogel Mitigates Damage to the Right Ventricle of the Heart

An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journals of the American College of Cardiology: Basic to Translational Science.  The study, by a research team from the University of California San Diego, Georgia Institute of Technology and Emory University, was conducted in rodents.

Ochsner Children’s Hospital advocates to close the gap in pediatric heart care

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Expert Available: Interventional Cardiology Procedures for Congenital Heart Defects

According to the Centers for Disease Control and Prevention, 40,000 babies are born with these defects annually. Ochsner Children’s Hospital offers minimally invasive procedures, such as catheterization, to repair conditions like Atrial Septal Defect, Patency of the Ductus Arteriosus, and Valve…

Nationwide Children’s Hospital Emphasizes Importance of Lifesaving AED & CPR Training for Schools and Communities

While sudden cardiac arrest is rare, it can happen to anyone at any time – including children, non-athletes and healthy individuals. Educating youth and adults to act swiftly and use an AED when they witness medical emergencies can help save lives. The AED is a portable electronic device that automatically diagnoses potentially life-threatening heart rhythms and delivers a shock only if necessary.

Fetal Echoes: Caring for the Heart During Pregnancy

As the nation continues to recognize American Heart Month, the Smidt Heart Institute’s Ruchira Garg, MD, director of Congenital Noninvasive Cardiology in the Guerin Family Congenital Heart Program at Cedars-Sinai, and Susanna Tran, MD, sat down with the Cedars-Sinai Newsroom to spotlight specialized fetal imaging.

Children’s Hospital Los Angeles Experts Present on the Latest in Pediatric and Congenital Cardiovascular Diseases at 25th Annual Cardiology 2022 Conference

Twenty-six Children’s Hospital Los Angeles physicians, nurses and leaders will serve as presenters at the 25th Annual Cardiology 2022 Conference, themed “The New Normal: Transformation in Pediatric & Congenital Heart Disease.”

Ochsner Hospital for Children Named #1 in Louisiana by U.S. News & World Report for the Second Year in a Row

Ochsner Hospital for Children has been named #1 in Louisiana in the new Best Children’s Hospitals for 2022 – 23 rankings published online today for the second consecutive year by U.S. News & World Report – the global authority in hospital rankings and consumer advice.

Children’s Hospital Los Angeles: 美国加州和太平洋地区最好的儿童护理机构

《美国新闻与世界报道》再次将 CHLA 评为其本州加利福尼亚州和美国太平洋地区(包括阿拉斯加州、加利福尼亚州、夏威夷州、俄勒冈州和华盛顿州)的最佳儿童医院。CHLA 还连续 14 年(自该排名诞生以来从未缺席)入选该刊年度“最佳儿童医院榜”——美国领先儿科机构权威榜单——最终名列第 8 位。

Fostering Innovation in Congenital Interventional Cardiology

Children’s Hospital Los Angeles is evaluating several novel devices for congenital heart disease—and recently performed the world’s first implant of a novel stent for babies. Since joining Children’s Hospital Los Angeles in August as the Director of Congenital Interventional Catheterization, Darren Berman, MD, has been expanding the scope of the Cardiac Catheterization Lab to include many of the newest catheter-based treatments for children and young adults with congenital heart disease.

What Parents Should Know about Multisystem Inflammatory Syndrome in Children (MIS-C)

MIS-C stands for multisystem inflammatory syndrome in children. Formerly called pediatric inflammatory multisystem syndrome, or PIMS, it describes a new health condition seen in children who have been infected with novel coronavirus, recovered from it and later have an immune response that results in symptoms of significant levels of inflammation in organ systems. MIS-C is similar in some ways to other inflammatory conditions like Kawasaki disease and toxic shock syndrome. Children who have MIS-C generally did not have obvious symptoms when they were infected with novel coronavirus, like cough, and generally were healthy prior to developing MIS-C.